✦ LIBER ✦

Bioequivalence studies of a new valproic acid delayed-release capsule and divalproex sodium delayed-release tablet

✍ Scribed by Garikipati, Vandana; Toops, Dana S.; Fang, Qi

Book ID: 111871658
Publisher: Informa plc
Year: 2008
Tongue: English
Weight: 137 KB
Volume: 24
Category: Article
ISSN: 0300-7995
DOI: 10.1185/03007990802122735

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Formulation development and evaluation o

Formulation development and evaluation of bi layer tablets: a fixed dose combination of sumatriptan succinate and naproxen sodium as immediate release layer and sumatriptan succinate as delayed release layer

✍ Koteswari, Poluri; Puttugunta, Srinivasa Babu; Vadlatala, Gangadhar 📂 Article 📅 2014 🏛 Springer Netherlands 🌐 English ⚖ 733 KB

The use of Monte Carlo simulations to st

The use of Monte Carlo simulations to study the effect of poor compliance on the steady state concentrations of valproic acid following administration of enteric-coated and extended release divalproex sodium formulations

✍ Alaa M. Ahmad; F. Douglas Boudinot; William H. Barr; Ronald C. Reed; William R. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

## Abstract Divalproex sodium extended‐release (Depakote^®^ ER) is a once daily (QD) formulation for valproic acid that was developed to improve patient compliance and to reduce side effects compared with the standard twice‐daily (BID) delayed release (DR) formulation (Depakote^®^ tablets). However

A comparative clinical and pharmacokinet

A comparative clinical and pharmacokinetic study of a new slow-release versus conventional preparations of valproic acid in children with intractable epilepsy

✍ Imaizumi, Tomoichi; Izumi, Tatsuro; Fukuyama, Yukio 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 508 KB

Safety and Tolerability of a New Formula

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

✍ , Prof. Gavin R. Graff Professor and Chief Pediatric Pulmonology, John McNamara, 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 179 KB

DEVELOPMENT AND VALIDATION OF A STABILIT

DEVELOPMENT AND VALIDATION OF A STABILITY INDICATING RP-LC METHOD FOR THE ESTIMATION OF PROCESS RELATED IMPURITIES AND DEGRADATION PRODUCTS OF DULOXETINE HYDROCHLORIDE AND PHTHALIC ACID IN DULOXETINE HYDROCHLORIDE DELAYED RELEASE CAPSULES

✍ Kumar, Navneet; Sangeetha, D.; Vaghela, Bhupendrasinh; Reddy, P. Sunil; Raghav, 📂 Article 📅 2012 🏛 Taylor and Francis Group 🌐 English ⚖ 593 KB

Efficacy and tolerability of a new formu

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

✍ Gavin R. Graff; Karen Maguiness; John McNamara; Ronald Morton; David Boyd; Katri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB